XIth Eurasian Hematology-Oncology Congress - EHOC 2020
A

Lymphoblastic Lymphoma: How Effective Are ALL-Regimen Therapy and CHOP-Like Chemo? What Is the Role of AutoSCT and RT?

By XIth Eurasian Hematology-Oncology Congress - EHOC 2020 FEATURING Alina Antipova
By XIth Eurasian Hematology-Oncology Congress - EHOC 2020 FEATURING Alina Antipova
0 views
January 12, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Recommended

AUTOPLAY
08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
09:27
ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin
16:25
Northwestern Medicine Oncology and Hematology

Diagnosis and Goals of Therapy in PV

Feat. B. Stein
13:34
EULAR 2023 Insights

EULAR 2023 Insights: From Pathogenesis to Therapy in Sjögren's …

Feat. H. Bootsma
06:51
Insights from 2023 ASH Annual Meeting

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Feat. D. Tremblay
10:49
Monia Marchetti

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
26:31
UChicago Medicine

Practical Aspects of Bispecifics in NHL: Supportive Care and Minimiz…

Feat. K. Kelly
15:32
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

The Potential Role of ctDNA in Hodgkin Lymphoma Management

Feat. I. Panovska-Stavridis
23:17
Cedars Sinai

Medical Therapy Related Complications in IBD

Feat. M. Long
22:11
19th Annual International Ultmann Chicago Lymphoma Symposium

High-Grade B-Cell Lymphomas, Not Otherwise Specified: How To Differe…

Feat. D. Scott
34:29
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies

Moffitt Cancer Center Debate: Should NGS Be Reported in All Newly Di…

Feat. B. Shah, H. Saeed
33:52
Houston Methodist Hospital

Review and Updates of New and Upcoming Cytopathology Reporting Syste…

Feat. E. M. Jacobi
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
16:57
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Lymphoma Highlights"

Feat. B. D. Cheson
13:07
Moffitt Cancer Center

R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?

Feat. J. Chavez
22:09
Scripps Health

New Updates in Frontline DLBCL

Feat. L. Nastoupil
12:49
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Treatment of Relapsed HL - Updated Options…

Feat. P. Johnson